This announcement is a separate document:
圣达生物：浙江圣达生物药业股份有限公司2022年半年度报告摘要
Shengda Biotech: Summary of the 2022 semi-annual report of Zhejiang Shengda Biopharmaceutical Co., Ltd.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.